Individual investors who hold 51% of Immunome, Inc. (NASDAQ:IMNM) gained 15%, institutions profited as well
Key Insights Immunome's significant individual investors ownership suggests that the key decisions are influenced by...
Stay updated with breaking news from Morphimmune Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Key Insights Immunome's significant individual investors ownership suggests that the key decisions are influenced by...
WEST LAFAYETTE, Ind., June 06, 2022 (GLOBE NEWSWIRE) -- Universities impact lives in their local communities through the success of their alumni, by...
WEST LAFAYETTE, Ind., June 06, 2022 (GLOBE NEWSWIRE) -- Universities impact lives in their local communities through the success of their alumni, by hosting educational and artistic events, and in
WEST LAFAYETTE, Ind., June 06, 2022 (GLOBE NEWSWIRE) -- Universities impact lives in their local communities through the success of their alumni, by...
/PRNewswire/ -- MorphImmune, Inc., a private platform company that is advancing a highly specific targeting technology that uses a ligand-linked payload to...